Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-01-08
1998-09-01
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31415
Patent
active
058011889
ABSTRACT:
This invention provides methods for intraspinal administration of therapeutically-effective amounts of clonidine for alleviating acute and chronic pain.
REFERENCES:
patent: 3202660 (1965-08-01), Zeile et al.
patent: 4122190 (1978-10-01), Lancranjan
patent: 4692147 (1987-09-01), Duggan
patent: 4921853 (1990-05-01), LeBlanc
patent: 5459133 (1995-10-01), Neufeld
patent: 5523316 (1996-06-01), Gan et al.
Derwent Abstract No. 96-42061, Zakel et al., Acta anaesthesiol. Scand., 40, Suppl 109, p. 223, 1996.
Derwent Abstract No. 95-41208, Eisenach, et al. Anesthesiology 83, No. 1, pp. 33-47, 1995.
Roxane Laboratories, Inc., "DURACLON clonidine HCI Injection", Sep. 1996.
Roxane Laboratories, Inc., "Block another path of pain", Feb. 1997.
Quan et al., "Clonidine in Pain Management," Ann. of Pharmc., V27, pp. 313-314 (1993).
Eisenach et al., "Site of Hemodynamic Effects of Intrathecal .alpha..sub.2 -Adrenergic Agonists," Anesthesiology, V74, pp. 766-771 (1991).
Filos et al., "Intrathecal Clonidine as a Sole Analgesic for Pain Relief after Cesarean Section," Anesthesiology, V77, pp. 267-274 (1992).
Filos et al., "Hemodynamic and Analgesic Profile after Intrathecal Clonidine in Humans," Anesthesiology, V81, pp. 591-601, (1994).
Edeburn Patrick
Hassenbusch, III Samuel J.
Trissel Lawrence A.
Henley III Raymond
Medtronic Inc.
LandOfFree
Clonidine therapy enhancement does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Clonidine therapy enhancement, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clonidine therapy enhancement will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-270633